Parameter
| Biomarker | IL-1β | Full name | serum interleukin-1β | Molecular Type | cell factor |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Inflammatory mechanism research and targeted therapy evaluation | ||
| Disease | Osteoarthritis (OA) | Disease Subtypes | / | ||
| Organ | Joint (Synovium) | Test Sample / Technology Platform | Serum (ELISA, flow cytometry) | ||
| Pathobiological Mechanisms | Promoting intra-articular inflammation and cartilage degradation is a key inflammatory factor in inflammatory osteoarthritis | ||||
| Clinical Availability Status | Research phase | ||||
| Notes and Dynamics | IL-1β inhibitors (such as anabyliside) have been used in clinical practice, and serum IL-1β levels can be assessed to evaluate treatment efficacy. | ||||